IDEAYA receives FDA approval to begin IDE034 clinical trial
Enrolment for the trial is scheduled to start in the first quarter of 2026.
Syngene Thematic ADC WP
MSD and Daiichi Sankyo commence Phase III breast cancer therapy trial
CytomX to continue Phase I ADC trial despite patient death
PDS Biotechnology completes recruitment for stage one of colorectal cancer trial
China’s NMPA approves initiation of InnoCare’s trial of B7-H3 targeted ADC
Bio-Thera Solutions doses first subject in Phase III ADC ovarian cancer trial
